Paradigms for Treating Breast Cancers Have Changed: The One-Size-Fits-All Is no Longer True
Main Article Content
Keywords
Breast cancer, Treatment, New paradigm in Breast Cancer management
Abstract
NA
References
1. Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321(3):288-300.
2. Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life. 2015;8(2):176-80.
3. Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303-10.
4. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918-26.
5. Sanz J, Zhao M, Rodriguez N, Granado R, Foro P, et al. Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients. Biomed Res Int. 2018;2018:8321871.
6. Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, et al. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells. 2019;8(10).
2. Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life. 2015;8(2):176-80.
3. Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303-10.
4. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918-26.
5. Sanz J, Zhao M, Rodriguez N, Granado R, Foro P, et al. Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients. Biomed Res Int. 2018;2018:8321871.
6. Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, et al. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells. 2019;8(10).
Article Sidebar
Article Details
How to Cite
1.
Salmon R. Paradigms for Treating Breast Cancers Have Changed: The One-Size-Fits-All Is no Longer True. Arch Breast Cancer [Internet]. 2019 Nov. 30 [cited 2023 Jun. 5];:141-6. Available from: https://www.archbreastcancer.com/index.php/abc/article/view/263
Section
Invited Commentary
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.
Article Statistics :Views : 469 | Downloads : 547